Corindus Vascular Robotics (OTC:CVRS) said today that it inked a Japanese distribution deal for its CorPath GRX device that includes a $2 million advance and provision for 12 of the robot-assisted surgery platforms. The deal with MC Healthcare subsidiary Japan Medicalnext calls for an initial order of a dozen systems within 30 days with a $2 million advance toward the…

Corindus Vascular Robotics (OTC:CVRS) said today that its CorPath GRX 2nd-generation vascular robot-assisted surgery platform was used in its 1st commercial procedures. The robotic platform was used early this month at the NewYork-Presbyterian hospital, UC San Diego Health and University of Virginia Health System in robotic-assisted PCI procedures, the company said. It began early installations of…

Robotic surgery is taking off, and the field is becoming increasingly diverse. We’ve collected information on the biggest players in the field so far. Intuitive Surgical’s da Vinci robot remains the premier surgical robotics company, with other companies including Stryker and Zimmer-Biomet only getting into the field in recent years. Read on to find out more.…

Shares in Corindus Vascular Robotics (OTC:CVRS) jumped nearly 11% in morning trading today after the company raised its outlook for full-year revenue in 2017 to between $13 million – $15 million. Analysts have pegged the robotic-assisted systems maker’s full-year revenue for 2017 at $12 million. Corindus said in a report yesterday that it anticipates implementation of at least…